Research Advisory Panel content
The Research Advisory Panel provides a critical role in helping to evaluate funding proposals, ensuring we only fund the best research that fits most closely with the Charity’s mission: Taking action today to have the biggest impact on cancer for people in Yorkshire.
Our panel consists of stakeholders and experts and their primary role is assessing applications for funding. Our independent stakeholders are patients, lay people and those who work or have worked in cancer healthcare. Our experts are respected subject opinion leaders including researchers, scientists, clinicians and commercial experts. These important people represent a considerable breadth of knowledge and experience in national and international research.
The Panel meets to assess applications in our funding rounds and discuss how these fit in with the objectives of the Charity. There are two stages: the Strategic Fit Test and the Research Advisory Meeting.
As well as the funding round, we have other opportunities throughout the year where the input of Stakeholders on our research is extremely valuable.
The purpose of the Panel is to provide advice and comment on the merits of each research application to enable the Executive to make appropriate funding recommendations to the Board of Trustees, which satisfy the Charity’s core purpose and strategic aims.
Throughout our application review process, we ensure any conflicts of interest are identified and managed appropriately and we treat everything with the strictest of confidence.
Apply to join
If you would like more information or are interested in joining the panel, please contact the Research Team by emailing research@ycr.org.uk or calling 01423 613483.
Quote from Naggina Asaf
As a Yorkshire Cancer Research stakeholder panel member for the last 2 years, I have really enjoyed participating in how the vision for the future is shaped. Analysis of funding applications with my peers has taught me new skills I can take forward. Having the opportunity to do some media work to increase uptake for cervical cancer screening has allowed me the opportunity to help educate young women from a Muslim background to the importance of screening to prevent future cancer deaths and allow for early intervention.
Research Advisory Panel Members
We have two cohorts on our panel, Stakeholders and Experts and their primary role is with the assessment of applications in our annual funding rounds.
Stakeholders
Mrs Christine Allmark
Mrs Naggina Asaf
Mrs Samina Begum
Mrs Debbie Beirne
Ms Sylvia Bergin
Ms Ruby Bhatti OBE
Prof Nick Bosanquet
Mr Peter Buckle
Mrs Jackie Buxton
Dr Martie Duvenage
Mr Neil Garner
Mr Peter Hogg
Mrs Rehana Haq
Mrs Saima Javeed
Ms Annie Jones
Mrs Allyson Kent
Mrs Tracy Lister
Dr Robert Maida
Mr Paul Newman
Mrs Alison Port
Miss Stacey Sewell
Mr David Spillane
Ms Sara Williamson
Mrs Theeda Phe Kali Winter
Experts
Prof Samreen Ahmed
Leicester teaching hospitals (Hon prof at university), Consultant in Medical Oncology
Professor Athene Lane
Professor of Trials Research
Mr Tim Batchelor
St Bartholomew’s Hospital, London
Dr Richard Booton
University of Manchester, Manchester Thoracic Oncology Centre
Dr Lucy Brindle
University of Southampton, Faculty of Health Sciences
Professor John Britton
University of Nottingham, Emeritus Professor of Epidemiology
Dr Christine Campbell
University of Edinburgh, College of Medicine and Veterinary Medicine
Prof Helen Coleman
Queen’s University Belfast, Centre for Public Health
Prof Jack Cuzick
Queen Mary University of London, Wolfson Institute of Preventive Medicine
Prof Amanda Daley
University of Loughborough, School of Sport, Exercise and Health Sciences
Miss Farhat V N Din
University of Edinburgh, Clinician Scientist & Honorary Consultant Colorectal Surgeon
Prof Stephen Duffy
Queen Mary University London, Wolfson Institute of Preventive Medicine
Prof Helena Earl
Prof Douglas Easton
Professor of Genetic Epidemiology & Director of the Centre for Cancer Genetic Epidemiology, University of Cambridge
Prof Richard Emsley
King's College London, Professor of Medical Statistics & Trials Methodology
Prof Emma Hall
The Institute of Cancer Research
Dr Michelle Harvie
University of Manchester, Manchester Breast Centre
Dr David Landau
King’s College London, Guy’s and St Thomas’ NHS Trust
Prof Kwok Leung Cheung
Professor of Breast Surgery and Medical Education, Faculty of Medicine & Health Sciences, University of Nottingham
Dr Anne Mackie
Public Health England (London & South East), Director of Screening
Prof Jane Maher
Macmillan Cancer Support, Chief Medical Officer
Prof Usha Menon
UCL, Professor of Gynaecological Cancer
Prof Peter Murchie
University of Aberdeen, Institute of Applied Health Science
Dr Neal Navani
University College London Hospitals, Clinical Lead for Lung Cancer and Bronchoscopy
Prof Caitlin Notley
University of East Anglia, Norwich Medical School, Professor of Addiction Sciences
Prof Mary O’Brien
Royal Marsden Hospital NHS Foundation Trust, Consultant Medical Oncologist and the Head of the Lung Unit
Dr Deepak Prashar
University of Warwick
Prof Andrew Renehan
University of Manchester, Division of Cancer Sciences
Dr Angela Rodrigues
Northumbria University, Senior Lecturer in Health Psychology
Prof Greg Rubin
Newcastle University, Institute of Health and Society
Prof Suzanne Scott
Queen Mary University of London
Prof Lion Shahab
University College London, Institute of Epidemiology and Health
Prof Debbie Sharp
University of Bristol, Bristol Population Health Science Institute
Dr Rohini Sharma
Imperial College London, Senior lecturer & Imperial College Healthcare NHS Trust (Hammersmith Hospital), Honorary Consultant
Prof Linda Sharp
Royal Victoria Infirmary (Newcastle), Sir James Spence Institute
Dr Jessica Sheringham
University College London, Dept. of Applied Health Research
Prof Robert Steele
University of Dundee, School of Medicine
Prof James Turner
Dr Christian Von Wagner
University College London, Institute of Epidemiology and Health
Prof Eila Watson
Oxford Brookes University, School of nursing and Midwifery
Prof Sally Wyke
University of Glasgow, Institute of Health & Wellbeing
Quote from John McGhee
"I have found the whole experience of being a lay member of the panel tremendously rewarding. To read the applications for funding, see them through the process and then hear about the sometimes life changing final outcomes makes my little bit of effort so worthwhile."
Quote from Prof. Ananya Choudhury
"As a member of the Advisory Panel for Yorkshire Cancer Research for 4 years, it was a privilege to be involved in shaping research strategy, enabling better outcomes for people with cancer and bringing innovation to cancer care."